Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcutis Biotherapeutics Inc (ARQT)
:ARQT
RESEARCH TOOLSreports
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 04, 2025 | Patrick Burnett Reporting Person's Title: Evp, Chief Medical Officer | xxxxxxxxxxxxx | $153873 |
| Feb 04, 2025 | Todd Franklin Watanabe Reporting Person's Title: President And Ceo,director | xxxxxxxxxxxxx | $245123 |
| Dec 31, 2024 | Patrick Burnett Reporting Person's Title: Evp, Chief Medical Officer | xxxxxxxxxxxxx | $23674 |
| Nov 26, 2024 | Patrick Burnett Reporting Person's Title: Evp, Chief Medical Officer | xxxxxxxxxxxxx | $162473 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $373839 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $15277992 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $54368664 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,867,706 | Insider | 5.20% | 62,209,283 | |
| 5,893,129 | Institution | 5.03% | 75,314,189 | |
| 5,195,518 | Institution | 4.44% | 66,398,720 | |
| 5,026,230 | Institution | 4.29% | 64,235,219 | |
| 3,553,838 | Institution | 3.04% | 45,418,050 | |
| 3,085,198 | Institution | 2.64% | 39,428,830 | |
| 2,735,010 | Institution | 2.34% | 34,953,428 | |
| 2,476,615 | Institution | 2.12% | 31,651,140 | |
| 1,525,545 | Institution | 1.30% | 19,496,465 | |
| 1,358,500 | Institution | 1.16% | 17,361,630 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,195,518 | Institution | 4.44% | 66,398,720 | |
| 3,085,198 | Institution | 2.64% | 39,428,830 | |
| 2,735,010 | Institution | 2.34% | 34,953,428 | |
| 1,525,545 | Institution | 1.30% | 19,496,465 | |
| 1,283,621 | Institution | 1.10% | 16,404,676 | |
| 1,161,642 | Institution | 0.99% | 14,845,785 | |
| 1,048,227 | Institution | 0.90% | 13,396,341 | |
| 903,900 | Institution | 0.77% | 11,551,842 | |
| 606,041 | Institution | 0.52% | 7,745,204 | |
| 490,568 | Institution | 0.42% | 6,269,459 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,269,949 | Institution | 2.79% | 45,550,390 | |
| 2,884,513 | Institution | 2.46% | 36,864,076 | |
| 2,251,714 | Institution | 1.92% | 27,718,599 | |
| 1,578,418 | Institution | 1.35% | 21,987,363 | |
| 961,813 | Institution | 0.82% | 12,291,970 | |
| 742,299 | Institution | 0.63% | 9,137,701 | |
| 645,562 | Institution | 0.55% | 8,250,282 | |
| 510,455 | Institution | 0.44% | 7,110,638 | |
| 504,818 | Institution | 0.43% | 6,214,310 | |
| 340,298 | Institution | 0.29% | 4,740,351 |
FAQ
Who Owns Arcutis Biotherapeutics Inc (ARQT)?
Currently, no data Available
What percentage of Arcutis Biotherapeutics Inc (ARQT) stock is held by institutional investors?
Currently, no data Available
What percentage of Arcutis Biotherapeutics Inc (ARQT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Arcutis Biotherapeutics Inc (ARQT)?
Steven A. Cohen owns the most shares of Arcutis Biotherapeutics Inc (ARQT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.